2023-03-08 12:37:33 ET
- Agilent Technologies ( NYSE: A ) is in a global distribution agreement with Proscia to deliver a comprehensive digital diagnostic pathology system.
- The plan is to combine Agilent's ( A ) trusted pathology staining solutions with Proscia's Concentriq Dx enterprise pathology platform.
- Proscia's scalable platform assists primary diagnostic workflows from individual labs to large laboratories.
- It is designed to provide a digital environment for viewing, managing, and analyzing images, as well as leverage artificial intelligence.
- Seeking Alpha's Quant Rating views Agilent as a hold with high marks for profitability and revisions .
For further details see:
Agilent in distribution agreement with Proscia on digital diagnostic pathology system